{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "CDK-2/6", "VEGFR-2", "dynamic simulation", "molecular docking", "phytochemical study", "topoisomerase-1"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35406868", "DateRevised": {"Year": "2022", "Month": "04", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "26"}], "Language": ["eng"], "ELocationID": ["888", "10.3390/plants11070888"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Mar", "Day": "26"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Characterization of Promising Cytotoxic Metabolites from <i>Tabebuia guayacan</i> Hemsl.: Computational Prediction and In Vitro Testing.", "Abstract": {"AbstractText": ["Genus <i>Tabebuia</i> is famous for its traditional uses and valuable phytoconstituents. Our previous investigation of <i>Tabebuia</i> species noted the promising anticancer activity of <i>T. guayacan</i> Hemsl. leaves extract, however, the mechanism underlying the observed anticancer activity is still unexplored. The current research was designed to explore the phytochemical content as well as to address the phytoconstituent(s) responsible for the recorded anticancer activity. Accordingly, sixteen compounds were isolated, and their structures were elucidated using different spectroscopic techniques. The drug-likeness of the isolated compounds, as well as their binding affinity with four anticancer drug target receptors: CDK-2/6, topoisomerase-1, and VEGFR-2, were evaluated. Additionally, the most promising compounds were in vitro evaluated for inhibitory activities against CDK-2/6 and VEGFR-2 enzymes using kinase assays method. Corosolic acid (<b>3</b>) and luteolin-7-<i>O</i>-\u03b2-glucoside (<b>16</b>) were the most active inhibitors against CDK-2 (-13.44 kcal/mol) and topoisomerase 1 (-13.83 kcal/mol), respectively. Meanwhile, quercetin 3-<i>O</i>-\u03b2-xyloside (<b>10</b>) scored the highest binding free energies against both CDK-6 (-16.23 kcal/mol) as well as against VEGFR-2 protein targets (-10.39 kcal/mol). Molecular dynamic simulation indicated that quercetin 3-<i>O</i>-\u03b2-xyloside (<b>10</b>) exhibited the least fluctuations and deviations from the starting binding pose with RMSD (2.6 \u00c5). Interestingly, in vitro testing results confirmed the potent activity of <b>10</b> (IC<sub>50</sub> = 0.154 \u00b5g/mL) compared to IC<sub>50</sub> = 0.159 \u00b5g/mL of the reference drug ribociclib. These findings suggest the three noted compounds (<b>3</b>, <b>10,</b> and <b>16</b>) for further in vivo anticancer studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Giza 12613, Egypt."}], "LastName": "El-Hawary", "ForeName": "Seham S", "Initials": "SS"}, {"Identifier": ["0000-0001-9683-4250"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt."}], "LastName": "Mohammed", "ForeName": "Rabab", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Nahda University, Beni-Suef 62521, Egypt."}], "LastName": "Taher", "ForeName": "Marwa A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt."}], "LastName": "AbouZid", "ForeName": "Sameh Fekry", "Initials": "SF"}, {"Identifier": ["0000-0002-0179-8398"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University, Beni-Suef 62521, Egypt."}], "LastName": "Mansour", "ForeName": "Mostafa A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraidah 51452, Saudi Arabia."}], "LastName": "Almahmoud", "ForeName": "Suliman A", "Initials": "SA"}, {"Identifier": ["0000-0002-7813-117X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia."}], "LastName": "Huwaimel", "ForeName": "Bader", "Initials": "B"}, {"Identifier": ["0000-0002-7190-3974"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraidah 51452, Saudi Arabia."}], "LastName": "Amin", "ForeName": "Elham", "Initials": "E"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Shawky A.M., Ibrahim N.A., Abourehab M.A., Abdalla A.N., Gouda A.M. Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities. J. Enzym. Inhib. Med. Chem. 2021;36:15\u201333. doi: 10.1080/14756366.2020.1837124.", "ArticleIdList": ["10.1080/14756366.2020.1837124", "PMC7594867", "33103497"]}, {"Citation": "Tadesse S., Caldon E.C., Tilley W., Wang S. Cyclin-dependent kinase 2 inhibitors in cancer therapy: An update. J. Med. Chem. 2018;62:4233\u20134251. doi: 10.1021/acs.jmedchem.8b01469.", "ArticleIdList": ["10.1021/acs.jmedchem.8b01469", "30543440"]}, {"Citation": "Yousuf M., Khan P., Shamsi A., Shahbaaz M., Hasan G.M., Haque Q.M.R., Hassan M.I. Inhibiting CDK6 activity by quercetin is an attractive strategy for cancer therapy. ACS Omega. 2020;5:27480\u201327491. doi: 10.1021/acsomega.0c03975.", "ArticleIdList": ["10.1021/acsomega.0c03975", "PMC7594119", "33134711"]}, {"Citation": "Nebenfuehr S., Kollmann K., Sexl V. The role of CDK6 in cancer. Int. J. Cancer Res. 2020;147:2988\u20132995. doi: 10.1002/ijc.33054.", "ArticleIdList": ["10.1002/ijc.33054", "PMC7586846", "32406095"]}, {"Citation": "Riess C., Irmscher N., Salewski I., Str\u00fcder D., Classen C.F., Gro\u00dfe-Thie C., Maletzki C. Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma\u2014Backbone or add-on in immune-oncology. Cancer Metastasis Rev. 2021;40:153\u2013171. doi: 10.1007/s10555-020-09940-4.", "ArticleIdList": ["10.1007/s10555-020-09940-4", "PMC7897202", "33161487"]}, {"Citation": "Hoff P.M., Machado K.K. Role of angiogenesis in the pathogenesis of cancer. Cancer Treat. Rev. 2012;38:825\u2013833. doi: 10.1016/j.ctrv.2012.04.006.", "ArticleIdList": ["10.1016/j.ctrv.2012.04.006", "22677191"]}, {"Citation": "Huang L., Huang Z., Bai Z., Xie R., Sun L., Lin K. Development and strategies of VEGFR-2/KDR inhibitors. Future Med. Chem. 2012;4:1839\u20131852. doi: 10.4155/fmc.12.121.", "ArticleIdList": ["10.4155/fmc.12.121", "23043480"]}, {"Citation": "Moukharskaya J., Verschraegen C. Topoisomerase 1 inhibitors and cancer therapy. Hematol. Oncol. Clin. 2012;26:507\u2013525. doi: 10.1016/j.hoc.2012.03.002.", "ArticleIdList": ["10.1016/j.hoc.2012.03.002", "22520977"]}, {"Citation": "Solowey E., Lichtenstein M., Sallon S., Paavilainen H., Solowey E., Lorberboum-Galski H. Evaluating medicinal plants for anticancer activity. Sci. World J. 2014;2014:721402. doi: 10.1155/2014/721402.", "ArticleIdList": ["10.1155/2014/721402", "PMC4248331", "25478599"]}, {"Citation": "De Almeida E.R., da Silva Filho A.A., Dos Santos E.R., Lopes C.A.C. Antiinflammatory action of lapachol. J. Ethnopharmacol. 1990;29:239\u2013241. doi: 10.1016/0378-8741(90)90061-W.", "ArticleIdList": ["10.1016/0378-8741(90)90061-W", "2374436"]}, {"Citation": "Castellanos J.R.G., Prieto J.M., Heinrich M. Red Lapacho (Tabebuia impetiginosa)\u2014A global ethnopharmacological commodity. J. Ethnopharmacol. 2009;121:1\u201313. doi: 10.1016/j.jep.2008.10.004.", "ArticleIdList": ["10.1016/j.jep.2008.10.004", "18992801"]}, {"Citation": "Ferreira-J\u00fanior J.C., Conserva L.M., Lemos R.P.L., de Omena-Neta G.C., Cavalcante-Neto A., Barreto E. Isolation of a dihydrobenzofuran lignan, icariside E 4, with an antinociceptive effect from Tabebuia roseo-alba (Ridley) Sandwith (Bignoniaceae) bark. Arch. Pharm. Res. 2015;38:950\u2013956. doi: 10.1007/s12272-014-0468-4.", "ArticleIdList": ["10.1007/s12272-014-0468-4", "25138119"]}, {"Citation": "Nirmala M.J., Samundeeswari A., Sankar P.D. Natural plant resources in anti-cancer therapy\u2014A review. Res. Plant Biol. 2011;1:1\u201314."}, {"Citation": "El-Hawary S.S., Taher M.A., AbouZid S.F., Amin E., Mohammed R. Genus Tabebuia: A comprehensive review journey from past achievements to future perspectives. Arab. J. Chem. 2021;14:103046. doi: 10.1016/j.arabjc.2021.103046.", "ArticleIdList": ["10.1016/j.arabjc.2021.103046"]}, {"Citation": "El-Hawary S.S., Mohammed R., Tawfike A.F., AbouZid S.F., Taher M.A., Abdelmohsen U.R., Amin E. Metabolic profiling of cytotoxic metabolites from five Tabebuia species supported by molecular correlation analysis. Sci. Rep. 2021;11:8405. doi: 10.1038/s41598-021-87695-w.", "ArticleIdList": ["10.1038/s41598-021-87695-w", "PMC8052319", "33863934"]}, {"Citation": "Pagadala N.S., Syed K., Tuszynski J. Software for molecular docking: A review. Biophys. Rev. 2017;9:91\u2013102. doi: 10.1007/s12551-016-0247-1.", "ArticleIdList": ["10.1007/s12551-016-0247-1", "PMC5425816", "28510083"]}, {"Citation": "Sahu S.N., Pattanayak S.K. Molecular docking and molecular dynamics simulation studies on PLCE1 encoded protein. J. Mol. Struct. 2019;1198:126936. doi: 10.1016/j.molstruc.2019.126936.", "ArticleIdList": ["10.1016/j.molstruc.2019.126936"]}, {"Citation": "Wei M., Zhao R., Cao Y., Wei Y., Li M., Dong Z., Yang C. First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo. Eur. J. Med. Chem. 2021;209:112903. doi: 10.1016/j.ejmech.2020.112903.", "ArticleIdList": ["10.1016/j.ejmech.2020.112903", "33256948"]}, {"Citation": "Wiseman L.R., Markham A. Irinotecan. Drugs. 1996;52:606\u2013623. doi: 10.2165/00003495-199652040-00013.", "ArticleIdList": ["10.2165/00003495-199652040-00013", "8891470"]}, {"Citation": "Sun S., Zhang J., Wang N., Kong X., Fu F., Wang H., Yao J. Design and discovery of quinazoline-and thiourea-containing sorafenib analogs as EGFR and VEGFR-2 dual TK inhibitors. Molecules. 2018;23:24. doi: 10.3390/molecules23010024.", "ArticleIdList": ["10.3390/molecules23010024", "PMC5943947", "29295519"]}, {"Citation": "Aliba M.O., Ndukwe I.G., Ibrahim H. Isolation and characterization of \u0392-sitosterol from methanol extracts of the stem bark of large-leaved rock fig (Ficus abutilifolia Miq) JASEM. 2018;22:1639\u20131642. doi: 10.4314/jasem.v22i10.19.", "ArticleIdList": ["10.4314/jasem.v22i10.19"]}, {"Citation": "Woo K.W., Han J.Y., Choi S.U., Kim K.H., Lee K.R. Triterpenes from Perilla frutescens var. acuta and their cytotoxic activity. Nat. Pro. Sci. 2014;20:71\u201375."}, {"Citation": "Birhanu G. Isolation of ursolic acid from the leaves of Ocimum lamiifolium collected from Addis Ababa Area, Ethiopia. Afr. J. Biotechnol. 2020;19:65\u201370."}, {"Citation": "Xu S., Wang G., Peng W., Xu Y., Zhang Y., Ge Y., Gong Z. Corosolic acid isolated from Eriobotrya japonica leaves reduces glucose level in human hepatocellular carcinoma cells, zebrafish and rats. Sci. Rep. 2019;9:4388. doi: 10.1038/s41598-019-40934-7.", "ArticleIdList": ["10.1038/s41598-019-40934-7", "PMC6416347", "30867526"]}, {"Citation": "Soares A.D.O., Tieppo C., Soares L.R., Corsino J., Souza A.F., Garcez F.R., Garcez W.S. Iridoides, triterpenos e outros constituintes das cascas do caule e flores de Tabebuia caraiba Bignoniaceae. Quim. Nova. 2020;43:399\u2013403. doi: 10.21577/0100-4042.20170513.", "ArticleIdList": ["10.21577/0100-4042.20170513"]}, {"Citation": "Aquino R., De Simone F., Vincieri F.F., Pizza C., Ga\u0107s-Baitz E. New polyhydroxylated triterpenes from Uncaria tomentosa. J. Nat. Prod. 1990;53:559\u2013564. doi: 10.1021/np50069a004.", "ArticleIdList": ["10.1021/np50069a004", "2213029"]}, {"Citation": "Rai N.P., Adhikari B.B., Paudel A., Masuda K., Mckelvey R.D., Manandhar M.D. Phytochemical constituents of the flowers of Sarcococca coriacea of Nepalese origin. J. Nepal Chem. Soc. 2006;21:1\u20137. doi: 10.3126/jncs.v21i0.214.", "ArticleIdList": ["10.3126/jncs.v21i0.214"]}, {"Citation": "Liu H., Mou Y., Zhao J., Wang J., Zhou L., Wang M., Yang F. Flavonoids from Halostachys caspica and their antimicrobial and antioxidant activities. Molecules. 2010;15:7933. doi: 10.3390/molecules15117933.", "ArticleIdList": ["10.3390/molecules15117933", "PMC6259280", "21060300"]}, {"Citation": "Scotti L., Fernandes M.B., Muramatsu E., Emereciano V.D.P., Tavares J.F., Silva M.S.D., Scotti M.T. 13C NMR spectral data and molecular descriptors to predict the antioxidant activity of flavonoids. Braz. J. Pharm. Sci. 2011;47:241\u2013249. doi: 10.1590/S1984-82502011000200005.", "ArticleIdList": ["10.1590/S1984-82502011000200005"]}, {"Citation": "Kuru\u00fcz\u00fcm-Uz A., G\u00fcvenalp Z., Kazaz C., Demirezer L.\u00d6. Phenolic compounds from the roots of Anchusa azurea var. azurea. Turk. J. Pharm. Sci. 2013;10:177\u2013184."}, {"Citation": "Yan X., Murphy B.T., Hammond G.B., Vinson J.A., Neto C.C. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon) J. Agric. Food Chem. 2002;50:5844\u20135849. doi: 10.1021/jf0202234.", "ArticleIdList": ["10.1021/jf0202234", "12358448"]}, {"Citation": "Kalegari M., Miguel M.D., Dias J.D.F.G., Lordello A.L.L., Lima C.P.D., Miyazaki C.M.S., Miguel O.G. Phytochemical constituents and preliminary toxicity evaluation of leaves from Rourea induta Planch. (Connaraceae) Braz. J. Pharm. Sci. 2011;47:635\u2013642. doi: 10.1590/S1984-82502011000300023.", "ArticleIdList": ["10.1590/S1984-82502011000300023"]}, {"Citation": "Zhang H., Conte M.M., Huang X.C., Khalil Z., Capon R.J. A search for BACE inhibitors reveals new biosynthetically related pyrrolidones, furanones and pyrroles from a southern Australian marine sponge, Ianthella sp. Org. Biomol. Chem. 2012;10:2656\u20132663. doi: 10.1039/c2ob06747a.", "ArticleIdList": ["10.1039/c2ob06747a", "22361689"]}, {"Citation": "Makhmoor T., Choudhary M.I. Radical scavenging potential of compounds isolated from Vitex agnus\u2014Castus. Turk. J. Chem. 2010;34:119\u2013126."}, {"Citation": "Dinh N.T., Ngo X.L., Thi H.T., Thi H.N., Thi H.M.V., Thi N.M.N., Vu T.K.O. Chemical constituents from ethyl acetate extract of the leaves of Rourea harmandiana Pierre. Vietnam J. Sci. Technol. Eng. 2020;62:30\u201333. doi: 10.31276/VJSTE.62(2).30-33.", "ArticleIdList": ["10.31276/VJSTE.62(2).30-33"]}, {"Citation": "Ganbaatar C., Gruner M., Mishig D., Duger R., Schmidt A.W., Kn\u00f6lker H.J. Flavonoid glycosides from the aerial parts of Polygonatum odoratum (Mill.) Druce growing in Mongolia. Nat. Prod. J. 2015;8:1\u20137. doi: 10.2174/1874848101508010001.", "ArticleIdList": ["10.2174/1874848101508010001"]}, {"Citation": "Lin L.C., Pai Y.F., Tsai T.H. Isolation of luteolin and luteolin-7-O-glucoside from Dendranthema morifolium Ramat Tzvel and their pharmacokinetics in rats. J. Agric. Food Chem. 2015;63:7700\u20137706. doi: 10.1021/jf505848z.", "ArticleIdList": ["10.1021/jf505848z", "25625345"]}, {"Citation": "Lynch T., Price A.L. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am. Fam. Physician. 2007;76:391\u2013396.", "ArticleIdList": ["17708140"]}, {"Citation": "Shiri F., Shahraki S., Baneshi S., Nejati-Yazdinejad M., Majd M.H. Synthesis, characterization, in vitro cytotoxicity, in silico ADMET analysis and interaction studies of 5-dithiocarbamato-1, 3, 4-thiadiazole-2-thiol and its zinc (ii) complex with human serum albumin: Combined spectroscopy and molecular docking investigations. RSC Adv. 2016;6:106516\u2013106526."}, {"Citation": "Lu H., Chang D.J., Baratte B., Meijer L., Schulze-Gahmen U. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin. J. Med. Chem. 2005;48:737\u2013743. doi: 10.1021/jm049353p.", "ArticleIdList": ["10.1021/jm049353p", "15689157"]}, {"Citation": "Khuntawee W., Rungrotmongkol T., Hannongbua S. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex. J. Chem. Inf. Model. 2012;52:76\u201383. doi: 10.1021/ci200304v.", "ArticleIdList": ["10.1021/ci200304v", "22172011"]}, {"Citation": "Imberty A., Hardman K.D., Carver J.P., Perez S. Molecular modelling of protein-carbohydrate interactions. Docking of monosaccharides in the binding site of concanavalin A. Glycobiology. 1991;1:631\u2013642. doi: 10.1093/glycob/1.6.631.", "ArticleIdList": ["10.1093/glycob/1.6.631", "1822243"]}, {"Citation": "Shewchuk L., Hassell A., Wisely B., Rocque W., Holmes W., Veal J., Kuyper L.F. Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. J. Med. Chem. 2000;43:133\u2013138. doi: 10.1021/jm990401t.", "ArticleIdList": ["10.1021/jm990401t", "10633045"]}, {"Citation": "Belkadi A., Kenouche S., Melkemi N., Daoud I., Djebaili R. K-means clustering analysis, ADME/pharmacokinetic prediction, MEP, and molecular docking studies of potential cytotoxic agents. Struct. Chem. 2021;32:2235\u20132249. doi: 10.1007/s11224-021-01796-w.", "ArticleIdList": ["10.1007/s11224-021-01796-w"]}, {"Citation": "El-Helby A.G.A., Ayyad R.R., Sakr H., El-Adl K., Ali M.M., Khedr F. Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR-2 Inhibitors. Arch. Pharm. 2017;350:1700240. doi: 10.1002/ardp.201700240.", "ArticleIdList": ["10.1002/ardp.201700240", "29131379"]}, {"Citation": "Yadav D.K., Khan F. QSAR, docking and ADMET studies of camptothecin derivatives as inhibitors of DNA topoisomerase-I. J. Chemom. 2013;27:21\u201333. doi: 10.1002/cem.2488.", "ArticleIdList": ["10.1002/cem.2488"]}, {"Citation": "Boudjedir A., Kraim K., Saihi Y., Attoui-Yahia O., Ferkous F., Nacereddine A.K. A computational molecular docking study of camptothecin similars as inhibitors for topoisomerase 1. J. Struct. Chem. 2021;32:689\u2013697. doi: 10.1007/s11224-020-01633-6.", "ArticleIdList": ["10.1007/s11224-020-01633-6"]}, {"Citation": "Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massagu\u00e9 J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 1995;376:313\u2013320. doi: 10.1038/376313a0.", "ArticleIdList": ["10.1038/376313a0", "7630397"]}, {"Citation": "Ram\u00edrez D., Caballero J. Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data. Molecules. 2018;23:1038. doi: 10.3390/molecules23051038.", "ArticleIdList": ["10.3390/molecules23051038", "PMC6102569", "29710787"]}, {"Citation": "Allam A.E., Amen Y., Ashour A., Assaf H.K., Hassan H.A., Abdel-Rahman I.M., Shimizu K. In silico study of natural compounds from sesame against COVID-19 by targeting M pro, PL pro and RdRp. RSC Adv. 2021;11:22398\u201322408. doi: 10.1039/D1RA03937G.", "ArticleIdList": ["10.1039/D1RA03937G"]}, {"Citation": "Galvez M., Mart\u0131n-Cordero C., Lopez-Lazaro M., Cortes F., Ayuso M.J. Cytotoxic effect of Plantago spp. on cancer cell lines. J. Ethnopharmacol. 2003;88:125\u2013130. doi: 10.1016/S0378-8741(03)00192-2.", "ArticleIdList": ["10.1016/S0378-8741(03)00192-2", "12963131"]}, {"Citation": "Chowdhury A.R., Sharma S., Mandal S., Goswami A., Mukhopadhyay S., Majumder H.K. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem. J. 2002;366:653\u2013661. doi: 10.1042/bj20020098.", "ArticleIdList": ["10.1042/bj20020098", "PMC1222798", "12027807"]}, {"Citation": "Adegbola P.I., Semire B., Fadahunsi O.S., Adegoke A.E. Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for COVID-19. VirusDisease. 2021;32:85\u201397. doi: 10.1007/s13337-021-00682-7.", "ArticleIdList": ["10.1007/s13337-021-00682-7", "PMC8036013", "33869672"]}, {"Citation": "Li Y., Gao Z.H., Qu X.J. The adverse effects of sorafenib in patients with advanced cancers. Basic Clin. Pharmacol. Toxicol. 2015;116:216\u2013221. doi: 10.1111/bcpt.12365.", "ArticleIdList": ["10.1111/bcpt.12365", "25495944"]}, {"Citation": "Gunasekaran T., Haile T., Nigusse T., Dhanaraju M.D. Nanotechnology: An effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pac. J. Trop. Biomed. 2014;4:S1\u2013S7. doi: 10.12980/APJTB.4.2014C980.", "ArticleIdList": ["10.12980/APJTB.4.2014C980", "PMC4025268", "25183064"]}, {"Citation": "Mansour M.A., AboulMagd A.M., Abdel-Rahman H.M. Quinazoline-Schiff base conjugates: In silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins. RSC Adv. 2020;10:34033\u201334045. doi: 10.1039/D0RA06424F.", "ArticleIdList": ["10.1039/D0RA06424F"]}, {"Citation": "Staker B.L., Feese M.D., Cushman M., Pommier Y., Zembower D., Stewart L., Burgin A.B. Structures of three classes of anticancer agents bound to the human topoisomerase I\u2013DNA covalent complex. J. Med. Chem. 2005;48:2336\u20132345. doi: 10.1021/jm049146p.", "ArticleIdList": ["10.1021/jm049146p", "15801827"]}, {"Citation": "Hasegawa M., Nishigaki N., Washio Y., Kano K., Harris P.A., Sato H., Cheung M. Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors. J. Med. Chem. 2007;50:4453\u20134470. doi: 10.1021/jm0611051.", "ArticleIdList": ["10.1021/jm0611051", "17676829"]}, {"Citation": "Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kale L., Schulten K. Scalable molecular dynamics with NAMD. J. Comput. Chem. 2005;26:1781\u20131802. doi: 10.1002/jcc.20289.", "ArticleIdList": ["10.1002/jcc.20289", "PMC2486339", "16222654"]}, {"Citation": "MacKerell A.D., Jr., Bashford D., Bellott M., Dunbrack R.L., Evanseck J.D., Field M.J., Fischer S., Gao J., Guo H., Ha S. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. 1998;102:3586\u20133616. doi: 10.1021/jp973084f.", "ArticleIdList": ["10.1021/jp973084f", "24889800"]}, {"Citation": "Jo S., Kim T., Iyer V.G., Im W. Charmm-Gui: A web-based graphical user interface for Charmm. J. Comput. Chem. 2008;29:1859\u20131865. doi: 10.1002/jcc.20945.", "ArticleIdList": ["10.1002/jcc.20945", "18351591"]}, {"Citation": "Jo S., Jiang W., Lee H.S., Roux B.t., Im W. Charmm-Gui Ligand Binder for absolute binding free energy calculations and its application. ACS Pub. 2013;53:267\u2013277. doi: 10.1021/ci300505n.", "ArticleIdList": ["10.1021/ci300505n", "PMC3557591", "23205773"]}, {"Citation": "Al-Salem H.S., Arifuzzaman M., Alkahtani H.M., Abdalla A.N., Issa I.S., Alqathama A., Rahman A.F.M. A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor. Molecules. 2020;25:4400. doi: 10.3390/molecules25194400.", "ArticleIdList": ["10.3390/molecules25194400", "PMC7582667", "32992673"]}, {"Citation": "Zeidan M.A., Mostafa A.S., Gomaa R.M., Abou-Zeid L.A., El-Mesery M., Magda A.A., Selim K.B. Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors. Eur. J. Med. Chem. 2019;168:315\u2013329. doi: 10.1016/j.ejmech.2019.02.050.", "ArticleIdList": ["10.1016/j.ejmech.2019.02.050", "30826508"]}, {"Citation": "Wang Y., Chen Y., Cheng X., Zhang K., Wang H., Liu B., Wang J. Design, synthesis and biological evaluation of pyrimidine derivatives as novel CDK2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells. Bioorg. Med. Chem. 2018;26:3491\u20133501. doi: 10.1016/j.bmc.2018.05.024.", "ArticleIdList": ["10.1016/j.bmc.2018.05.024", "29853338"]}, {"Citation": "Pires D.E., Blundell T.L., Ascher D.B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "23"}, {"Year": "2022", "Month": "3", "Day": "15"}, {"Year": "2022", "Month": "3", "Day": "21"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "1", "Minute": "5"}, {"Year": "2022", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "13", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "3", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["35406868", "PMC9002841", "10.3390/plants11070888", "plants11070888"]}}], "PubmedBookArticle": []}